Zymeron Corporation
Zymeron Corporation received $0 in federal prime contract obligations in the 12 months ending Oct 5, 2026, and $13.3M since FY2022. Its largest customer is the Department of Defense.
See 1 contracts ending in the next 18 months ↓Contractor details
- Unique Entity ID (UEI)
- GAMMMRQ6QMN1
- CAGE code
- 7MVB7
- Headquarters
- Durham, NC
- Business size
- Small Business
As recorded on this UEI's most recent prime contract action in USAspending.gov. Confirm current registration and certifications in SAM.gov.
Obligations by fiscal year
Net prime contract obligations by federal fiscal year.
Top agencies
Funding agencies ranked by obligations since FY2022.
| Funding agency | Latest 12 mo | Since FY2022 |
|---|---|---|
| Department of Defense | $0 | $12.8M |
| Department of Health and Human Services | $0 | $486K |
Top NAICS codes
Industry codes agencies recorded on this contractor's awards, since FY2022.
What it sells
Product and service codes (PSC) on this contractor's awards, since FY2022.
| PSC | Description | Since FY2022 |
|---|---|---|
| AN12 | Health R&D services; Health Care services; Applied Research | $6.7M |
| AN11 | Health R&D services; Health Care services; Basic Research | $5.4M |
| AC12 | National Defense R&D services; Department of Defense - military; Applied Research | $990K |
| AJ11 | General Science and Technology R&D services; General Science and technology; Basic Research | $197K |
| AC31 | National Defense R&D services; Defense-Related activities; Basic Research | $167K |
Contracts ending in the next 18 months
This contractor's largest awards whose current period of performance ends soon. Options and extensions often move these dates.
| Award | Agency | Obligated | Current end |
|---|---|---|---|
| HT942524C0057 | Department of Defense DHA SBIR DIRECT PHASE II H2D-0243 RAPID SAMPLE PROCESSING DEVICE TO SUPPORT BATTLEFIELD WOUND INFECTION DIAGNOSTICS | $3.0M | Jul 19, 2027 |
Recent awards
This contractor's newest prime contract awards, most recent first.
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| HT942524C0057 | Department of Defense DHA SBIR DIRECT PHASE II H2D-0243 RAPID SAMPLE PROCESSING DEVICE TO SUPPORT BATTLEFIELD WOUND INFECTION DIAGNOSTICS | $3.0M | Sep 12, 2024 |
| HT942524P0034 | Department of Defense DHA STTR PHASE 1 MEDICAL RESEARCH AND DEVELOPMENT PURCHASE ORDER FOR "PROPOSAL H23C-002-0028 "DEVELOPMENT OF WOUNDSHIELD FOR PSEUDOMONAS AERUGINOSA-CAUSED WOUNDS INFECTIONS" | $250K | Feb 13, 2024 |
| W911QY24P0008 | Department of Defense RESEARCH AND DEVELOPMENT | $197K | Dec 12, 2023 |
| HT942524P0004 | Department of Defense DHA STTR PH I PROPOSAL H23B-001-0020 ,TOPIC DHA23B-001-0020 TITLE AN AUTOMATED BLOOD-IN, MIRNAS-OUT ASSAY TO DETECT CIRCULATING AND EXOSOME MIRNAS EGS 2300543 MEDICAL R AND D | $250K | Oct 4, 2023 |
| HT942523C0067 | Department of Defense DHA SBIR DIRECT TO PH II MEDICAL R&D CONTRACT AWARDED FROM PROPOSAL NO.-H2D-0119 FOR "DEVELOPMENT FOR SHOCKDEFENDER AGAINST HEMORRHAGIC SHOCK" | $3.0M | Sep 14, 2023 |
| 75N91023C00034 | Department of Health and Human Services RAPID POINT OF CARE TEST TO SCREEN HUMAN PAPILLOMAVIRUS IN LOW-RESOURCE SETTINGS | $400K | Jul 28, 2023 |
| HT942523P0041 | Department of Defense ZYMERON DHA SBIR PHASE I H231-004-0023 NOVEL AEROSOL THERAPY FOR IMMEDIATE AND SUSTAINED ARDS MANAGEMENT | $250K | Jun 21, 2023 |
| 75N91022C00029 | Department of Health and Human Services SBIR TOPIC 441. ZYMERON WILL DEVELOP USER-FRIENDLY TECHNOLOGIES AND DEVICES TO CREATE AN AT-HOME HEPATITIS C VIRUS TEST. | $400K | Sep 19, 2022 |
Prime contracts (award types A–D) from USAspending.gov through Oct 5, 2026. Subcontracts are not included. Net obligations include deobligations and corrections.
Ready to connect your pursuit work?
GovEagle gives BD directors, capture managers, and proposal teams one AI workspace from pipeline through proposal, with CMMC/FedRAMP Certified compliance built in.